Types of Cancer We Treat

Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. We provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services, including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Find a Doctor & Schedule
Diagnosis
Surgery
Breast Reconstruction
Chemotherapy & Other Systemic Therapies
Radiation Therapy

Related News

Experimental Treatment Improves Survival for Breast Cancer
Read Story
Perlmutter Cancer Center Expands Clinical Trials Portfolio
Read Story
High-Tech Radiation Treatment Shortens Recovery Time
Read Story
Podcast: Breast Surgeon Becomes a Breast Cancer Survivor
Read Story
Breast Cancer & Immunotherapy
Read Story
Surviving Metastatic Breast Cancer
Read Story
Woman with Breast Cancer Battles COVID-19 at the Same Time
Read Story
Advances in Cancer Detection & Screening Guidelines
Read Story
Heart Attacks May Encourage Cancer Growth
Read Story
Timely Cancer Care During COVID-19 Makes All the Difference
Read Story
Mammogram Screening for Women with the BRCA Gene Mutation
Read Story
Radiologists & AI Together Better at Detecting Breast Cancer
Read Story

Clinical Trials and Research Studies

Phase 3

A Randomized Double-Blind Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Learn More

Phase -1

The Safety and Effectiveness of DuraSorb for Lower Pole Reinforcement in Patients Undergoing 2 Stage Breast Reconstruction

Learn More

Phase 5

A randomized Phase I/II trial of fulvestrant and abemaciclib in combination with copanlisib (FAC) versus fulvestrant and abemaciclib alone (FA) for endocrine-resistant hormone receptor positive HER2 negative metastatic breast cancer (FAC vs FA)

Learn More

Phase 1

A Phase 1 Multi-Targeted Study to Promote Anti-Tumor Immunity in ER Positive HER2 Negative Advanced Breast Cancer

Learn More
View All Related Clinical Trials (27)